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EvidEncE-basEd answEr
A
	 Do	antibiotics	improve		
outcomes	for	patients		
hospitalized	with	COPD		
exacerbations?
	 yes.	 Antibiotic	 use	 reduced	mor-
	 tality	 and	 treatment	 failure	 in	pa-
tients	 hospitalized	 with	 acute	 exacerba-
tions	 of	 chronic	 obstructive	 pulmonary	
disease	 (COPD)	 (strength	 of	 recommen-
dation	[SOR]:	A,	systematic	reviews	of	ran-
domized	controlled	trials	[RCTs]).
Giving	antibiotics	early	to	hospitalized	
patients	decreased	 the	need	 for	 later	ven-
tilation	 and	 readmission	 within	 30	 days	
for	exacerbation	of	COPD	(SOR:	B,	a	retro-
spective	cohort	study).
Evidence summary
A	systematic	review	of	4	RCTs	with	a	total	of	
356	patients	found	that	antibiotic	therapy	re-
duced	mortality	more	than	placebo	in	mod-
erately	 to	 severely	 ill	 hospitalized	 patients	
with	 COPD.	 Short-term	 mortality	 (7	 days	
after	 treatment	 to	 18	 months	 after	 hospital	
discharge)	decreased	by	77%	with	antibiotic	
use	in	acute	exacerbations	of	COPD	(number	
needed	to	treat	[NNT]=8;	95%	confidence	in-
terval	[CI],	6-17).
This	 same	 Cochrane	 review	 and	 a	 me-
ta-analysis	 of	 4	 hospital-based	 trials	 with	
321	 patients	 evaluated	 failure	 to	 improve,	
deterioration,	or	death	during	 the	 study	pe-
riod.1,2	The	results	favored	treatment	with	an-
tibiotics	over	placebo	(NNT=3;	95%	CI,	3-5).
Don’t wait to give antibiotics
A	 large	 retrospective	 cohort	 study	 of	 84,621	
hospitalized	 patients	 compared	 outcomes	
in	 patients	 given	 antibiotics	 for	 acute	 exac-
erbations	 of	 COPD	 during	 their	 first	 2	 days	
in	 the	hospital	with	patients	 treated	 later	 or	
not	at	all.3	Outcomes	assessed	included	need	
for	 later	 ventilation	 and	 readmission	within	
30	days	for	acute	exacerbations	of	COPD.
The	 study	 included	patients	 40	 years	 or	
older	 with	 a	 principal	 diagnosis,	 based	 on	
ICD	9	codes,	of	acute	exacerbation	of	COPD,	
emphysema,	 or	 respiratory	 failure	 paired	
with	 a	 secondary	 diagnosis	 of	 COPD	 with	
acute	 exacerbation	 or	 emphysema.	 Patients	
who	had	been	admitted	directly	to	the	inten-
sive	care	unit	were	excluded,	as	were	patients	
with	other	bacterial	infections,	such	as	pneu-
monia	or	 cellulitis,	 for	which	 they	might	 re-
ceive	antibiotics.
Early	 administration	 of	 antibiotics	 de-
layed	 the	 need	 for	 subsequent	 ventilation	
when	 compared	 with	 no	 antibiotics	 or	 an-
tibiotics	given	 later	 (1.07%	vs	1.80%;	P<.001;	
NNT=137).	 Giving	 antibiotics	 early	 also	
lowered	 readmission	 rates	 for	 acute	 exac-
erbations	of	COPD	 (7.91%	vs	 8.79%;	P<.001;	
NNT=114),	 improved	mortality	 rates	 (1.04%	
vs	 1.59%;	P<.001;	NNT=182),	 and	decreased	
treatment	 failure	 (9.77%	 vs	 11.75%;	 P<.001;	
NNT=51).
Recommendations
The	 recommendations	 of	 the	 Global	 Initia-
tive	 for	 Chronic	 Obstructive	 Lung	 Disease	
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(GOLD),	updated	in	2008,	call	for	antibiotics	
to	be	given	to	patients	with	2	or	more	of	the	
cardinal	 symptoms	 of	 acute	 exacerbations	
of	 COPD	 (shortness	 of	 breath,	 increased	
sputum	 production,	 and	 sputum	 puru-
lence).	 Patients	 with	 severe	 exacerbations	
who	require	a	ventilator	 should	also	 receive	
antibiotics.4
The	 Primary	 Care	 Consensus	 Guide-
lines	 from	 2004,	 consistent	 with	 the	 GOLD	
recommendations,	 state	 that	 a	 newer	 mac-
rolide,	 extended-spectrum	 cephalosporin,	
or	doxycycline	is	appropriate	for	moderately	
severe	exacerbations.	High-dose	amoxicillin/
clavulanate	or	a	respiratory	fluoroquinolone	
should	be	given	for	severe	exacerbations.5		JFP
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